Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Elevated circulating concentrations of platelet activating factor in preeclampsia.

B L Rowland1, S T Vermillion, W E Roudebush

  • 1Department of Obstetrics and Gynecology, Medical University of South Carolina 29401-9901, USA.

American Journal of Obstetrics and Gynecology
|October 18, 2000
PubMed
Summary

Circulating platelet activating factor (PAF) levels are significantly higher in women with preeclampsia. Increased PAF may indicate a risk marker for preeclampsia development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concentration of anti-Müllerian hormone in dairy heifers is positively associated with productive herd life.

Journal of dairy science·2015
Same author

Influence of the preimplantation-embryo-development (ped) gene on mouse blastocyst differentiation.

Zoological science·2008
Same author

Embryonic platelet-activating factor: an indicator of embryo viability.

Human reproduction (Oxford, England)·2002
Same author

Comparison of the coding sequence of the platelet-activating factor receptor gene in three species.

DNA sequence : the journal of DNA sequencing and mapping·2002
Same author

Platelet-activating factor increases intracellular calcium levels in preimplantation stage embryos.

Early pregnancy·2001
Same author

Effectiveness of a rescue dose of antenatal betamethasone after an initial single course.

American journal of obstetrics and gynecology·2001

Area of Science:

  • Reproductive Medicine
  • Biochemistry
  • Clinical Diagnostics

Background:

  • Preeclampsia is a serious pregnancy complication.
  • Platelet activating factor (PAF) is a potent lipid mediator.
  • The role of PAF in preeclampsia pathogenesis is not fully understood.

Purpose of the Study:

  • To investigate the association between preeclampsia and circulating platelet activating factor (PAF) levels.
  • To compare PAF concentrations across different study groups.

Main Methods:

  • A cross-sectional observational study was conducted.
  • Circulating PAF concentrations were measured using a radioimmunoassay.
  • Four groups were studied: nonpregnant women, normotensive pregnant women, women with preeclampsia, and normotensive men.

Related Experiment Videos

Main Results:

  • Mean circulating PAF concentration was significantly higher in women with preeclampsia compared to normotensive pregnant and nonpregnant women.
  • No significant differences were found between preeclamptic and normotensive male groups.
  • Normotensive pregnant women and nonpregnant women had similar PAF levels.

Conclusions:

  • Circulating PAF concentrations are elevated in pregnancies complicated by preeclampsia.
  • Platelet activating factor (PAF) may serve as a potential biomarker for preeclampsia risk.